NEW YORK (GenomeWeb News) – Celera presented data at the annual American Association for Cancer Research meeting describing its mass spectrometry-based approach to identify and validate circulating protein biomarkers that detect non-small cell lung cancer. The company said that one outcome of the study was an immunoassay test for a panel of six biomarkers that detected lung cancer with 94 percent sensitivity and 93 percent specificity in a blinded analysis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.